Financhill
Buy
73

EXLS Quote, Financials, Valuation and Earnings

Last price:
$46.35
Seasonality move :
2.77%
Day range:
$45.44 - $46.59
52-week range:
$28.16 - $52.43
Dividend yield:
0%
P/E ratio:
38.30x
P/S ratio:
4.14x
P/B ratio:
8.09x
Volume:
2.9M
Avg. volume:
1.2M
1-year change:
48.15%
Market cap:
$7.5B
Revenue:
$1.8B
EPS (TTM):
$1.21

EXLS Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for ExlService Holdings shares anticipate an average target of $55.00, ranging from a low estimate of $52.00 to a high estimate of $60.00. This average target implies a growth of 18.69% compared to the current stock price of $46.34.

Consensus Price Target

$55.00

Highest Price Target

$60.00

Lowest Price Target

$52.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 5 5

Hold 3 2 2

Sell 0 0 0
Consensus Buy Buy Buy

EXLS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock